Prenatalis® - Trusted Medical Quality

Prenatalis® is an accredited non-invasive prenatal test (NIPT) that based on the Illumina verifi® method, detects the incorrect distribution of chromosomes 21, 18 and 13 and sex chromosomes by the examination of cell-free fetal DNA in maternal blood. The analysis is possible from the 10th week of gestation for both single and twin pregnancies. The Prenatalis® test is performed completely by the Center for Human Genetics and Laboratory Diagnostics (MVZ) in Martinsried, Germany, without transferring information to third parties.

The Center for Human Genetics and Laboratory Diagnostics (MVZ Martinsried) offers NIPT within an interdisciplinary network of institutions specializing in prenatal medicine and human genetics. High quality standards are set for the provision of the Prenatalis® test calls, and there is an aim to promote NIPT research and development. The current status of developments and the medical advice regarding NIPT is continually discussed in a group of prenatal care providers, gynecologists and human geneticists.

Quality

As the only test based on the original technique from Illumina verifi®, Prenatalis® offers an unrivalled high sequencing depth and is therefore particularly suitable for difficult cases

  • With a low fetal fraction (in early pregnancy, obese patients)
  • In twin pregnancies
  • Following IVF/ICSI

Advantages of Prenatalis®

  • Test evaluation by medical-led laboratory in Germany
  • First DAkkS accredited NIPT in Germany
  • Highest sequencing depth (21 million reads) and determination of cell-free fetal DNA (cffDNA)
  • Access to a network of human genetic counselors
  • Access to advanced NIPT training courses
  • Qualification in human genetic counseling (see Guidelines for Genetic Counseling, paragraph VII.3.34, 72 training units), see also 8th communication of the Commision on Genetics Testing (GEKO) from 12.03.2014 )
  • Integration of NIPT into a professional and comprehensive prenatal medicine concept (ultrasound, biochemistry, infectious serology, chromosomal analysis, array-CGH, molecular genetics)
  • Initiation and organization of European Multicenter Studies for the further development of NIPT
  • Initiation and organization of external quality control testing (round robin tests)